Neurogene grants inducement stock options for 8,340 shares to five new employees
NGNE•Neurogene granted five new employees non-qualified stock options covering 8,340 common shares, dated Oct. 5, 2026. The options have an exercise price equal to the stock’s closing price that day and vest over four years, subject to continued employment.
1. Option grant details
The options are dated Oct. 5, 2026, with an exercise price set at the stock’s closing price that day. Twenty-five percent vest after one year, followed by monthly vesting of 1/48 of the award over three years, contingent on continued employment.
